Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about MYOV

Recent news which mentions MYOV

< Previous 1 2 3 Next >
Why Myovant Sciences Shares Are Skyrocketing Monday
Tickers MYOV
Tags Small Cap why it's moving Market News
From Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Tickers ALEC AMV APRN AREB
Tags WLDS ALEC LGHL
From InvestorPlace
Myovant Sciences Rejects Sumitovant/Sumitomo Pharma Buyout Offer Of $2.5B
Tickers MYOV
Tags why it's moving Market News M&A
From Benzinga
Why Myovant Sciences Is Trading Higher By Over 26%; Here Are 31 Stocks Moving Premarket
Tickers ACOR AGFY ALEC AMV
Tags ALEC HKD FNHC
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 9, 2022
Tickers AAWW AMTX ARGO AVLR
Tags VLTA TNDM HEAR
From Benzinga
Karuna Therapeutics To $276? Plus SVB Leerink Almost Doubles Price Target On This Stock
Tickers AMGN AUPH CECE CRMD
Tags AUPH CECE Small Cap
From Benzinga
FDA Approves Myovant Sciences/Pfizer's Treatment For Endometriosis-Associated Pain
Tickers MYOV PFE
Tags PFE MYOV Briefs
From Benzinga
Biotech Daily: Thumbs Down For Acadia's Antipsychotic Drug, Akebia Fails COVID-19 Study, Kazia's Encouraging Data In Brain Metastases
Tickers ACAD AKBA ALDX AMRX
Tags GMAB IBB ATNX
From Benzinga
Myovant Sciences's Return On Invested Capital Insights
Tickers MYOV
Tags MYOV BZI/ROCE Market News
From Benzinga
Biotech Investors: August's Key PDUFA Catalysts You Must Know
Tickers ACAD AMGN AXSM BGNE
Tags FDA IBB ACAD
From Benzinga
Myovant Sciences Ltd. (MYOV) Q1 2022 Earnings Call Transcript
Tickers MYOV
Tags Market News Recent Press Releases MYOV
From Motley Fool
Recap: Myovant Sciences Q1 Earnings
Tickers MYOV
Tags MYOV BZI/Recaps Market News
From Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Tickers ALVR BWV COSM CYH
Tags Market News TDOC SEEL
From Benzinga
Daily Biotech Pulse: Teva's Opioids Settlement, Criminal Investigation Against Cassava, Durable Responses For IN8bio's Leukemia Therapy
Tickers ALKS ALVR BMY CDTX
Tags Kate Watson Moss IBB Legal
From Benzinga
Earnings Scheduled For July 27, 2022
Tickers MOH MORN MPX MSA
Tags VICI NWE SF
From Benzinga
Earnings Outlook For Myovant Sciences
Tickers MYOV
Tags Market News Benzinga Earnings
From Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Tickers APRE AWH CLVS DARE
Tags RGLS OPGN SNDX
From Benzinga
FDA Accepts Myovant Sciences and Pfizer's Filing For Review In Uterine Fibroids
Tickers MYOV PFE
Tags PFE MYOV News
From Benzinga
Attention Biotech Investors: Mark Your Calendar For These June PDUFA Dates
Tickers ACAD ACER AMLX BLUE
Tags PHAT ACAD VRCA
From Benzinga
Urovant's OAB Gene Therapy Shows Improvement In Symptoms Compared To Placebo
Tickers MYOV
Tags Market News Health Care Trading Ideas
From Benzinga
103 Biggest Movers From Yesterday
Tickers AFI AFRM AHCO AKAN
Tags BODY CRON OPK
From Benzinga
Myovant Sciences Ltd. (MYOV) Q4 2021 Earnings Call Transcript
Tickers MYOV
Tags MYOV Market News Recent Press Releases
From Motley Fool
12 Health Care Stocks Moving In Tuesday's Intraday Session
Tickers AHCO AKAN AKBA BBLG
Tags CARA GDRX FGEN
From Benzinga
77 Stocks Moving In Tuesday's Mid-Day Session
Tickers AFRM AHCO AKAN ANGI
Tags HAE APPF LPSN
From Benzinga
The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO Leaves
Tickers AGEN ARWR ATNX AVGR
Tags Market News BAYRY XENE
From Benzinga
Myovant Sciences: Q4 Earnings Insights
Tickers MYOV
Tags MYOV BZI/Recaps News
From Benzinga
Earnings Preview: Myovant Sciences
Tickers MYOV
Tags Market News Earnings Benzinga
From Benzinga
Myovant, Accord Healthcare Ink Relugolix Distribution Pact For Europe In Prostate Cancer
Tickers MYOV
Tags General Small Cap Contracts
From Benzinga
U.S. FDA extends review of Pfizer and Myovant Sciences supplemental New Drug Application (sNDA) For MYFEMBREE by three months
Tickers MYOV PFE
Tags FDA Small Cap General
From Benzinga
Here's Why This Analyst Is On Sidelines Despite European Approval Of Myovant's Relugolix For Prostate Cancer
Tickers ABBV MYOV
Tags Analyst Ratings Analyst Color Market News
From Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.